Beyond conventional risk factors for cardiovascular disease, women face an additional
burden of sex-specific risk factors. Key stages of a woman's reproductive history may …

Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …

Osteoporosis is the most common metabolic bone disease in the USA and the world. It is a
subclinical condition until complicated by fracture (s). These fractures place an enormous …

“The 2022 Hormone Therapy Position Statement of The North American Menopause
Society”(NAMS) updates “The 2017 Hormone Therapy Position Statement of The North …

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for
women in the United States and worldwide. There has been no American College of …

Before menopause, women are protected from atherosclerotic heart disease associated with
obesity relative to men. Sex hormones have been proposed as a mechanism that …

Background Data suggest that estrogen-containing hormone therapy is associated with
beneficial effects with regard to cardiovascular disease when the therapy is initiated …

Abstract The Clinician's Guide to Prevention and Treatment of Osteoporosis was developed
by an expert committee of the National Osteoporosis Foundation (NOF) in collaboration with …

Objective: The objective of this document is to generate a practice guideline for the
management and treatment of symptoms of the menopause. Participants: The Treatment of …

Menopausal hormone therapy (HT) prescribing practices have evolved over the last few
decades guided by the changing understanding of the treatment's risks and benefits. Since …